Zdrowie i gospodarka · 06/09/2018
FDA Extends Comment Period for Human Gene Therapy Guidance Documents
The Food and Drug Administration is extending the comment period for six draft guidance documents related to human gene therapy products, in response to requests for an extension, to allow interested persons more time to submit comments and provide new information.